financetom
Business
financetom
/
Business
/
Magna Terra Minerals Says Partner Newmont Identified Priority Target Area At Boleadora Project
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Magna Terra Minerals Says Partner Newmont Identified Priority Target Area At Boleadora Project
Mar 26, 2024 6:21 AM

08:58 AM EDT, 03/26/2024 (MT Newswires) -- Magna Terra Minerals Inc. ( BRIOF ) said Tuesday that Newmont Corp. ( NEM ) subsidiary Oroplata SA has identified a priority target area on the Boleadora project in Argentina as part of a summary report of its 2023 exploration program.

Magna said assays from 2023 drainage sediment and rock-chip samples show that anomalous precious metals and pathfinder elements are associated with silica alteration, host fault zones, sinter structures and subtle hyperspectral responses that are indicative of deeper hydrothermal activity and gold mineralization at Newmont's ( NEM ) Cerro Negro mine.

Magna said Newmont ( NEM ) plans further follow-up exploration activities for 2024.

Boleadora comprises 55,000 hectares and is located 17 kilometers along strike from Newmont's ( NEM ) Cerro Negro mine.

Newmont ( NEM ) has an option to purchase Boleadora by paying US$1 million and granting a 2% net smelter royalty. Oroplata has made the third anniversary option payment of US$150,000 to Magna subsidiary Atala Resources SA under the agreement.

"We are very pleased to see Newmont ( NEM ), using their proprietary exploration techniques and expertise, continue to refine exploration targets on the Boleadora Project with recent work outlining a large 10 by 8 kilometer zone of anomalous precious-metal and pathfinder elements," Magna President and CEO Lew Lawrick said.

"This work supports the potential existence of a low-sulphidation epithermal environment associated with the Margaritas-Boleadoras Corridor along strike from the Cerro Negro mine."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved